Trial intelligence / Profile preview

MicroRepair® ABX vs Chlorhexidine in Plaque-Induced Gingivitis

NCT07088653Completed

Sponsor
University of Pavia
Start
Aug 2025
Primary completion
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of MicroRepair ABX in gingivitis (2 arms), sponsored by University of Pavia. Primary endpoint: Full Mouth Bleeding Score at 6 months. Started Aug 2025; status: completed.

02

Drugs

MicroRepair ABX
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT07088653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07088653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call